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Abstract. The authors presented the practical conclusions and therapeutic recommendations for the heavily 
bleeding patients, managed under combat conditions. Such therapy is vital for the wounded in the hostile tactical 
environment. The military medical solutions for assuring the effective hemostasis or applying the restrictive fluid 
therapy in internal bleeding cases may be useful also in civilian medicine. 
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Streszczenie. Autorzy przedstawili praktyczne wnioski i zalecenia postępowania w przypadku wystąpienia 
krwotoków w warunkach pola walki. Ich stosowanie ma kluczowe znaczenie dla osiągnięcia sukcesu i przeżycia 
rannych w niesprzyjających warunkach środowiska taktycznego. Doświadczenia medycyny wojskowej i praktyczne 
rozwiązania w celu zapewnienia skutecznej hemostazy lub zachowania restrykcyjnej płynoterapii w przypadku 
krwotoków wewnętrznych mogą znaleźć zastosowanie również w cywilnej opiece przedszpitalnej. 
Słowa kluczowe: krwotok, masywne krwawienie, polowa opieka nad rannym 
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Massive bleeding is the most frequent cause of death under 
combat conditions. Limb trauma is currently the main cause 
of bleeding [1]. Modern tactical protective gear (a ballistic 
vest, a kevlar helmet) protect the torso and the head of a 
soldier. At the same time, limbs remain exposed to direct 
trauma. Bleeding from limbs is the most common, potentially 
reversible cause of death in the battlefield. Combat medics 
can manage it by applying direct pressure to the place of 
bleeding and using a pressure dressing such as emergency 
bandage, Olaes or a tactical tourniquet.  
Conventional pressure is not, unfortunately, effective 
against bleeding into body cavities. This type of bleeding 
requires careful observation and management of the injured 
and, what is even more important, immediate evacuation of 
the injured to a level 2 field medical facility for the purposes 
of care and appropriate surgical treatment. 
A hemorrhage [2] is defined as the loss of: 
 1.5 ml/kg bodyweight/min of blood within 20 minutes, 
 150 ml/kg bodyweight/min of blood within 1 hour. 
Taking appropriate therapeutic actions has an influence 
on the dynamics and effects of bleeding. These actions 
include: 
 identification of a massive bleeding 
 applying the scoop and run approach in the case of an 
internal hemorrhage, 
 applying the stay and play approach in the case of an 
external hemorrhage, 
 performing correct local hemostasis (direct compression, 
a tactical tourniquet, wound packing, a local hemostatic 
agent, a pressure clamp), 
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Table 1. Classification of blood loss by American College of Surgeons (for a 70 kg, male) 
Tabela 1. Klasyfikacja utraty krwi Amerykańskiego Towarzystwa Chirurgów (dotyczy mężczyzny o masie ciała ok. 70 kg) 
 Class I Class II Class III Class IV 
blood loss (ml) <750 750-1500 1500-2000 >2000 
blood loss (% blood volume) <15 15-30 30-40 >40 
Pulse rate (per minute) <100 100-120 120-140 >140 
Blood pressure Normal or decreased Decreased Decreased Decreased 
Capillary refill time Normal Normal Extended Extended 
Respiratory rate (per minute) 14-20 20-30 30-35 >35 
Urine output (ml/h) >30 15-30 5-15 Negligible 
Mental status Fluid replacement Anxious Crystalloid Anxious 
Crystalloid 
Anxious, confused Crystalloid 
and blood 
Confused, lethargic 
Crystalloid and blood 
 
 
 influencing internal hemostasis (Tranexamic acid, 
TXA), 
 preventing hypothermia, 
 hypotensive fluid resuscitation (and fluids, if necessary) 
 immobilization of fractures, 
 pain management (ketamine vs. opioids) 
A combat medic is expected not only to dress 
bleeding properly, but also, depending on the trauma 
sustained by a soldier, to predict possible blood loss. 
It is estimated that an adult may lose: 
 1000-1500 ml of blood from a damaged lung 
 2000 ml of blood from a damaged liver, 
 2000 ml of blood from a damaged spleen, 
 3000-5000 ml of blood in the case of pelvic 
trauma, 
 1500-2000 ml of blood due to a fractured femur, 
 1000 ml of blood due to a crus fracture, 
 800 ml of blood due to a humerus fracture, 
 400 ml of blood due to the fracture of a forearm bone. 
A combat medic has to be familiar with this 
knowledge in order to plan appropriate treatment and 
implement a suitable fluid therapy and approach 
(scoop and run or stay and play) [3]. 
Hemorrhagic shock leads to tissue hypoxia and 
acidosis [4], thus increasing metabolic disturbances 
and worsening the patient's condition. 
The classification of blood loss-related symptoms 
by the American College of Surgeons (ACS) from 
1997 is a useful tool for combat medics. It allows 
them to classify the injured into four groups according 
to clinical symptoms, evaluate the approximate 
volume of blood loss and recommend the best form of 
fluid replacement. 
Based on the analysis of previous armed conflicts, 
a tourniquet has been regarded in the second half of 
the twentieth century as an unsafe tool to stop 
bleeding due to a number of complications related to 
the ischemia of limb muscles and nerves, and the 
frequent ineffectiveness of the device, usually 
resulting from its inappropriate physical properties. It 
appears that now, thanks to recent changes in its 
design and positive recommendations after its use in 
Iraq (Operation Iraqi Freedom) and Afghanistan 
(Operation Enduring Freedom), a tourniquet is 
experiencing a revival. There are two types of tactical 
tourniquets recommended for the contemporary 
battlefield: CAT (Combat Application Tourniquet) and 
SOFTT-W (Special Operation Forces Tactical 
Tourniquet-Wide). 
In the event of an exchange of fire (under fire), the 
first necessary action is to apply a tactical tourniquet 
to manage a life-threatening bleeding (Fig. 1 and 2). 
If actions taken as part of the tactical combat casualty 
care (TCCC) (direct compression, a pressure 
dressing) did not stop the bleeding, a medic should 
keep the pressure on the bleeding until surgical 
intervention, which should not exceed 2 hours [5,6]. 
According to the TCCC guidelines, a combat 
medic should apply a tactical tourniquet: 
 during the care under fire phase – on a uniform, as 
proximally as possible on a wounded limb (applied by 
the wounded soldier or by a combat medic),  
 during the tactical field care phase, in a safe (hidden) 
place – 2-3 inches above the wound, directly on the 
skin, if hemorrhage is impossible to stop by 
compression dressing or hemostatic agents (i.e. post-
traumatic amputations). 
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Figure 1. CAT tourniquet 
Rycina 1. Staza taktyczna CAT 
Figure 2. SOFTT-W tourniquet 
Rycina 2. Staza taktyczna SOFTT-W 
 
 if applying a tourniquet does not stop the 
bleeding, check the pressure of the tourniquet or 
apply another tourniquet proximally (above the 
first one), 
 since blood vessels may be hidden in the soft 
tissue between bones, hemostasis may be 
ineffective when applying compression to a 
forearm or a lower leg. If this is the case, it is 
recommended to apply a tourniquet to an arm or a 
thigh (one bone of which is along the limb axis) 
[5.7]. 
Tightening the tourniquet should stop the blood 
flow (no pulse) in a limb below the tourniquet. To 
indicate that the tourniquet has been applied, a 
combat medic should also mark the forehead or the 
cheek of the wounded soldier with a large letter "T", 
and also mark the tourniquet and the soldier's skin 
with the time of tightening and include the time in 
documentation. In the case of prolonged evacuation, 
consider releasing pressure from the limb after 2 
hours, but before doing so, use a combat gauze 
(QuikClot, Celox) as a local hemostatic agent. Apply 
pressure for at least 3 minutes using the combat 
gauze for direct contact with the wound and a normal 
gauze as a top layer. Release the tightened 
tourniquet only if the wounded soldier has a normal 
hemodynamic response to the administered fluids, 
which is reflected in the recovery of normal peripheral 
pulse and the improvement of mental status (if the 
soldier does not additionally suffer from a head 
trauma). In other words, if the wounded soldier is 
under the risk of a fatal bleeding, the priority is to 
save the life and not the limb. At any rate, keeping the 
tourniquet tightened for longer than 2 hours does not 
always lead to a limb amputation. The risk of 
complications resulting from limb ischemia and 
reperfusion injury is, however, greater in that case. 
A tactical tourniquet is effective in stopping a limb 
bleeding but it should be used only when other 
measures do not stop the bleeding (according to the 
evaluation by a trained medic). 
Kragh et al. [6] have demonstrated that the use of 
a tactical tourniquet has direct influence on survival in 
87% of the studied patients(p <0.001) and prevents 
the occurrence of hemorrhagic shock in 90% of the 
studied patients (p <0.001). They have also shown 
that the fatality rate was higher among cases where 
the tourniquet was applied with delay (11% under pre-
hospital conditions and as much as 24% after 
admission to hospital, p = 0.05). In 5 cases there 
were indications for the use of a tourniquet but other 
measures were applied, which turned out to be 
ineffective. As a consequence, the patients did not 
survive. 
Kragh et al. [8] have also revealed that the 
application of 428 tourniquets in 232 patients (to 309 
wounded limbs) did not increase fatality rate among 
the patients (lack of dependence) and did not lead to 
amputation. Only 4 patients (1.7%) suffered from 
complications in the form of residual paresthesia. The 
percentage of fasciotomies was 28% in patients 
whose time of tourniquet application was ≤2 hours (75 
of 272 patients) and 36% in patients whose time of 
tourniquet application was >2 hours (9 of 25 patients, 
p = 0.4). 
Nevertheless, the American College of Surgeons 
allows medics to use a tourniquet as part of Advanced 
Trauma Life Support only as a last resort, when direct 
pressure fails, accepting the tourniquet as a measure 
of choice in the case of post-traumatic amputation [9]. 
It also recommends using pneumatic pressure in 
hospital conditions. Swan's study [10] compares the 
effectiveness of tourniquets with direct compression 
to blood vessels in pressure points (commonly 
learned as part of first aid) in 10 healthy volunteers. 
The endpoint of the study was the loss of signal of 
distal blood flow in the vessel, as monitored by the 
Doppler device. Results of the study indicate that 
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while the application of a tourniquet is fully effective, 
using pressure points is ineffective at controlling 
bleeding. 
What is crucial in this matter is to provide 
medical personnel and battlefield operators with 
training on tourniquet application to control limb 
bleeding, which should minimize the percentage of 
preventable deaths caused by massive external 
bleeding in the battlefield. 
Hemostatic agents used in the battlefield 
There are two substances in use currently: 
 Kaolin - zeolite (QuikClot), 
 Chitosan (Celox, HemCon, WoundStat, 
ChitoGauze, ChitoFlex). 
Kaolin is an inert volcanic mineral containing 
silicon and clay, which is impregnated in the form of 
a combat gauze [Fig. 3]. It is non-toxic and it does 
not cause allergy. The currently used third 
generation of wound dressings with kaolin does not 
trigger adverse exothermic reactions that lead to 
tissue burns. The mechanism of hemostatic action is 
based on the activation of an internal coagulation 
cascade. Kaolin absorbs water from the surrounding 
area, activates factor XII, platelets and facilitates the 
formation of fibrin. Since the mineral is not 
biodegradable and removing it from the wound used 
to be problematic (it was used in the form of 
granules), it is currently used in the forms of a rolled 
or a Z-folded QuikClot combat gauze [Fig. 3] and a 
clotting sponge (QuikClot ACS+) [11,12]. 
Chitosan is manufactured from crustacean shells. 
It is a linear polysaccharide used in the form of 
granules. The mechanism of hemostatic action is 
based on the formation of a pseudo-clot and a gel 
dressing as a result of the exchange of electric 
charges between the substance and erythrocytes. 
Chitosan is a biodegradable material. Lysozyme 
breaks it down to glucosamine. It is used in the form 
of granules (Celox D), a dispenser with granules for 
penetrating wounds (Celox A), a gauze impregnated 
with the active substance (Celox Gauze [Fig. 4]) and 
adhesive dressing (HemCon). Advantages of 
chitosan include effectiveness at stopping bleeding 
in patients treated with warfarin derivatives or 
heparin and effective use in hypothermic patients, as 
the substance retains its hemostatic properties in 
contact with blood whose temperature lowers to 13-
18°C [11,12]. 
Local hemostatic agents should be used in body 
areas where a tactical tourniquet cannot be applied 
(the torso) and in the cases of junctional 
hemorrhage (occurring in the area of the neck, the 
axillary fossa or the groin). They are a better 
alternative to a tourniquet when it is necessary to 
stop local bleeding from a limb, even though they 
cannot replace the tourniquet in all cases. 
The use of a hemostatic agent must be 
accompanied by the application of constant pressure 
for at least 3-5 minutes. 
The American army presently recommends 
QuikClot and HemCon as hemostatic agents [7,11]. 
Soldiers in Polish military contingents are equipped 
with an individual medical kit (IPMed) which includes 
QuikClot (combat gauze) and Celox (gauze). Tactical 
operators and combat medics undergo training to 
learn what measure and what form of the measure 
they should use to achieve effective hemostasis. 
 
Figure 3. QuikClot Combat Gauze 
Rycina 3. Gaza hemostatyczna QuikClot 
 
Figure 4. Celox Gauze 
Rycina 4. Gaza hemostatyczna Celox 
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Figure 5. Combat Ready Clamp (CRoC) 
Rycina 5. Combat Ready Clamp (CRoC) 
 
Figure 6. Junctional Emergency Treatment Tool (JETT) 
Rycina 6. Junctional Emergency Treatment Tool (JETT) 
 
Figure 7. Abdominal Aortic & Junctional Tourniquet (AAJT) 
Rycina 7. Abdominal Aortic & Junctional Tourniquet (AAJT) 
Pressure clamps 
Estimates suggest that damage to great vessels in the 
pelvis is the cause of approximately 25% of hemorrhages. 
Bleeding from great vessels requires direct pressure 
[1,13,14]. In order to ensure effective action and release 
the hands of the medic applying the pressure, 3 systems to 
stop bleeding are currently in use: 
 
Figure 8. Israeli emergency bandage 
Rycina 8. Opatrunek izraelski 
 Combat Ready Clamp (CRoC [Fig. 5.]), 
 Junctional Emergency Treatment Tool (JETT [Fig. 
6]), 
 Abdominal Aortic & Junctional Tourniquet (AAJT 
[Fig. 7]). 
Their action is based on the external mechanical 
compression of groin tissues and the common iliac 
artery from one (CRoC) or two (JETT) sides or on the 
pneumatic pressure, the purpose of which is to 
compress the abdominal aorta and iliac arteries by 
increasing abdominal press (AAJT). 
TCCC guidelines recommend using a pressure clamp 
or the local application of a hemostatic agent, 
combined with applying direct pressure to the groin, 
depending on whether a device is unavailable or 
ready for use [5]. 
Pressure dressing 
External bleeding is frequently the effect of trauma, 
both in the battlefield and in the civilian environment. 
Luckily, not every bleeding is heavy, which means that 
taking such aggressive measures as the application of 
a pressure clamp or a local hemostatic agent is not 
always a necessity. 
The Emergency Bandage, also called the Israeli 
bandage, is a recognized measure for stopping 
bleeding [Fig. 8]. Manufactured for the army in four 
sizes (including the size for dressing abdominal 
wounds), the Emergency Bandage is elastic and 
contains a one-layer or a two-layer gauze pad with a 
clamp on top that is used to exert directional pressure. 
Another practical measure is Olaes Modular 
Bandage (Fig. 9), which is designed as a "3 in 1" 
pressure solution. The elastic roll of the bandage 
features a plastic pressure pad and a gauze to pack a 
wound. The bandage also has sewn in Velcro® control 
strips, which prevent the roll from accidental 
unwrapping. 
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Figure 9. OLAES Modular Bandage 
Rycina 9. Opatrunek OLAES 
Wound packing 
Some believe that direct pressure and appropriate wound 
packing with gauze is more important in stopping bleeding 
than the influence of a local hemostatic agent [12,15]. This 
is why tactical emergency training puts emphasis on the 
development and improvement of manual abilities to 
appropriately pack a wound using gauze, regardless of 
whether a hemostatic agent is used to manage bleeding 
wounds or not. 
Tranexamic acid (TXA) 
This active substance has been known for years and is 
currently experiencing a revival thanks to 
recommendations by the Committee on the Tactical 
Combat Casualty Care. It belongs to fibrinolysis inhibitors 
(dissolving blood clots) and prevents plasminogen from 
activation to plasmin. Indications for use in the battlefield 
are the following: symptoms of hemorrhagic shock, one or 
more severe amputations and penetrating wounds of the 
torso or multiple sources of bleeding. TCCC guidelines 
recommend administering 1 g of tranexamic acid (Exacyl®) 
in 100 ml of physiological NaCl solution or lactated Ringer's 
solution as quickly as possible and no later than 3 hours 
after trauma. The second dose of TXA (1 g) should be 
applied after administering Hextend (HAES, a colloidal 
solution) or after alternative fluid therapy [5]. It is used by 
medics under combat conditions. 
Hypotensive fluid resuscitation 
Tactical medics examining a shock may find the following 
evaluation parameters particularly useful: the mental state, 
the presence of radial pulse and its rate. Other useful (but 
not required) parameters include blood pressure, 
respiration rate, capillary refill time, anxiety and the sense 
of deadly threat [3,7]. 
Guidelines regarding the administration of crystalloid 
solutions are in contrast to restrictive guidelines for fluid 
therapy under combat conditions (intravenous, without 
fluids or transfusing small volumes of colloids). 
TCCC guidelines and US Army procedures for 
prehospital management of the injured soldier with 
identified hemorrhage dictate the following: 
 if the bleeding has been stopped and there are no 
symptoms of shock, do not transfuse fluids; 
 if the bleeding has been stopped and there are 
symptoms of shock, administer a 500 ml bolus of 
Hextend (HAES) intravenously; repeat after 30 minutes 
if shock symptoms persist (do not administer more than 
1000 ml of Hextend), 
 do not transfuse fluids in the case of uncontrolled 
internal (abdominal, thoracic) bleeding [5,7]. 
Hypotensive fluid resuscitation aims to maintain 
approximately 75% of the value of normal blood 
pressure, so that systolic blood pressure does not 
exceed 90 mm Hg and MAP is 40-50 mm Hg. 
Reducing intravenous fluid administration prevents the 
occurrence of coagulopathy resulting from dilution [3,7].  
In the case of hypotensive patients with penetrating 
trauma of the torso and severe head trauma, it is 
recommended to administer hypertonic NaCl solution in 
hydroxyethyl starch (HyperHAES) as part of fluid 
resuscitation [16,17].  
Normal rules for fluid resuscitation and crystalloids (see 
Table 1) should be applied: 
 in hemodynamically stable patients, 
 after stopping isolated external bleeding that is not 
compression resistant, 
 in severe head traumas (maintain the systolic blood 
pressure of <110 mm Hg), 
 in burns, 
 in the case of crush syndrome. 
Hypothermia 
Lowering body temperature by 1°C results in a 10-percent 
decrease in the ability to form a clot. Hypothermia, along 
with coagulopathy and acidosis, is a major 
pathomechanism contributing to the death of the injured 
person due to bleeding. Since warm fluids are not available 
under combat conditions, thermal equipment, such as the 
Ready Heat Blanket, and protective evacuation equipment, 
such as the Blizzard Survival Blanket and the Hypothermia 
Prevention and Management Kit (HPMK), is used to 
insulate the injured soldier and protect him or her against 
heat loss. Hypothermia prevention is a key factor in 
preventing the occurrence of systemic coagulation 
disturbances and fatal causes of bleeding diathesis [18]. 
Immobilization of fractures 
External stabilization of fractures (if possible, by the use of 
traction in the case of a fractured limb and compression in 
the case of pelvic fracture) significantly reduces bleeding 
and the need for analgesics. It is one of the priorities in the 
management of bleeding patients with fractures; a combat 
medic should immobilize a fracture after the careful 
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examination of the injured patient and the performance of 
emergency procedures (stopping the bleeding, clearing the 
airways, relieving a tension pneumothorax). 
Pain management under combat conditions 
The latest TCCC guidelines do not recommend 
administering opioids to patients with shock symptoms 
because opioids may disturb natural compensation 
mechanisms and worsen the patient's condition [19]. 
In the case of moderate to severe pain, and if the 
patient does not suffer from hemorrhagic shock and is 
not under the threat of shock, a medic should administer 
800 mg of oral transmucosal fentanyl citrate (OTFC). 
However, when the patient has symptoms of 
hemorrhagic shock or is under the threat of the shock, 
opioids should not be administered; instead, ketamine 
should be administered at the dose of 50 mg 
(intramuscular or by the use of an autoinjector) or 20 mg 
(intravenous or intramedullar gradual administration). A 
medic may repeat an intramuscular dose after 30 
minutes and an intravenous dose after 20 minutes. The 
endpoint of the therapy is pain relief or the occurrence of 
nystagmus in the patient [5]. 
Summary 
Delaying emergency procedures for stopping bleeding 
increases the risk of cardiovascular failure and 
decompensation in patients with rapid bleeding, even if 
a patient has been provided with fluid therapy. 
Therefore, guidelines for combat and tactical care 
indicate that stopping limb or junctional hemorrhage 
(occurring in the area of the neck, the axillary fossa or 
the groin) is a priority and should be performed even 
before clearing the airways. The indication results from 
an assumption that a human body handles short-term 
hypoxia more easily than the effects of hemorrhagic 
shock, bearing in mind major limitations of the tactical 
environment, delay in evacuation and limited access to 
blood preparations. Medical training of soldiers puts 
strong emphasis on the ability to apply a tactical 
tourniquet correctly, pack a wound and use modern 
hemostatic agents, which are included in the soldier's 
personal equipment. 
Bleeding into body cavities, on the other hand, 
requires immediate evacuation of the patient in order to 
implement surgical procedures for the management of 
bleeding. Tactical care of the injured soldier requires the 
prudent use of fluid therapy, the prevention of 
hypothermia and the administration of an appropriate 
analgesic. 
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